Following the long awaited interest rate rise in the US last month, the Federal Reserve might be under less pressure to raise rates over the coming months.
In a market laced with uncertainty and doubt, investors have more than turkey to chew on during the traditional festive period, and the mulled wine offers a welcome tonic after a year of anaemic growth and dashed expectations.
Companies in the US are feeling the pressure. The slowdown in global growth, for one, has had an impact on demand says Martin Currie's Tom Walker.
Keith Barrett, head of research at Ingenious Asset Management, asks whether outperformance in US healthcare stocks can continue or if it is time to take profits.
I do not want to be awkward or deliberately contrarian but has anyone noticed US equities look expensive again?
With the US economy stabilising over the past few years since the financial crisis, and a December rate hike looking increasingly more likely, the US recovery is underway.
There has been an increase in growth rate volatility, uncertainty of currency direction, and lack of clarity on interest rates this year, writes Douglas Burtnick, Aberdeen's deputy head of North American equities.
Tom Slater, co-manager of the £3.6bn Scottish Mortgage trust, will take over the role of head of the North American team at Baillie Gifford.
US stocks had a disappointing first three quarters of the year and volatility jumped as Federal Reserve uncertainty and Chinese growth concerns rattled investors.